Cargando…

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy

OBJECTIVES: To investigate the effect and its mechanisms of different antiviral agents on the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with chronic hepatitis B (CHB). METHODS: A total of 125 patients with CHB receiving nucleos(t)ide analogs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wen-Xin, Jia, Rui, Song, Jin-Wen, Zhang, Xiaoning, Zhou, Shuang-Nan, Wang, Fu-Sheng, Fu, Junliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748573/ https://www.ncbi.nlm.nih.gov/pubmed/36532454 http://dx.doi.org/10.3389/fmicb.2022.1056884

Ejemplares similares

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
por: Zhou, Jun, et al.
Publicado: (2005)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
por: Matveeva, Irina, et al.
Publicado: (2022)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

Modulation of Innate Antiviral Immune Response by Porcine Enteric Coronavirus
por: Zhang, Kunli, et al.
Publicado: (2022)

Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
por: Su, Xiaojie, et al.
Publicado: (2020)

The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
por: Tse, Longping V., et al.
Publicado: (2020)

Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
por: Yin, Di, et al.
Publicado: (2023)

Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines
por: Ambrosino, Donna, et al.
Publicado: (2021)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
por: Li, Juan, et al.
Publicado: (2021)

Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients
por: Wang, Wen-Xin, et al.
Publicado: (2023)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Induction and Suppression of Innate Antiviral Responses by Hepatitis A Virus
por: Cao, Xin, et al.
Publicado: (2018)

The regulation of antiviral activity of interferon epsilon
por: Zhao, Fu-Rong, et al.
Publicado: (2022)

Immune response after vaccination using inactivated vaccine for coronavirus disease 2019
por: Sun, Ya, et al.
Publicado: (2023)

Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes
por: Fu, Yang, et al.
Publicado: (2022)

Myricetin inhibits pseudorabies virus infection through direct inactivation and activating host antiviral defense
por: Hu, Huaiyue, et al.
Publicado: (2022)

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
por: Song, Jin-Wen, et al.
Publicado: (2022)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins
por: Xiang, Zhi-hao, et al.
Publicado: (2017)

Recent progress of antiviral therapy for coronavirus disease 2019
por: Zhao, Mengmeng, et al.
Publicado: (2021)

Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges
por: Song, Jin-Wen, et al.
Publicado: (2023)

Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
por: Kotecha, Rishi S., et al.
Publicado: (2015)

Evaluation of High-Pressure Processing in Inactivation of the Hepatitis E Virus
por: Nasheri, Neda, et al.
Publicado: (2020)

Coronavirus Disease 2019: Clinics, Treatment, and Prevention
por: Burkert, Francesco Robert, et al.
Publicado: (2021)

Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice
por: Zhao, Fu-jie, et al.
Publicado: (2022)

Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
por: Radcliffe, Christopher, et al.
Publicado: (2023)

Identifying shared genetic loci between coronavirus disease 2019 and cardiovascular diseases based on cross-trait meta-analysis
por: Guo, Hongping, et al.
Publicado: (2022)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin
por: Green, M., et al.
Publicado: (1992)

Delayed Antiviral Immune Responses in Severe Acute Respiratory Syndrome Coronavirus Infected Pregnant Mice
por: Zhu, Guohua, et al.
Publicado: (2022)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection
por: Shao, Xue, et al.
Publicado: (2017)

Antiviral Activity of Zinc Oxide Nanoparticles and Tetrapods Against the Hepatitis E and Hepatitis C Viruses
por: Gupta, Jyoti, et al.
Publicado: (2022)

Comparison of the Performance of 24 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in the Diagnosis of Coronavirus Disease 2019 Patients
por: Wu, Shiji, et al.
Publicado: (2022)

relA Inactivation Converts Sulfonamides Into Bactericidal Compounds
por: Si, Lizhen, et al.
Publicado: (2021)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Inactivation of Hepatitis A Virus and Human Norovirus in Clams Subjected to Heat Treatment
por: Fuentes, Cristina, et al.
Publicado: (2021)

Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019
por: Wang, Yan, et al.
Publicado: (2020)

Surveillance, epidemiology, and impact of the coronavirus disease 2019 interventions on the incidence of enterovirus infections in Nanchang, China, 2010–2022
por: Zhou, Xianfeng, et al.
Publicado: (2023)

Antiviral activity of zinc against hepatitis viruses: current status and future prospects
por: Kumar, Shiv, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fon2jd79tshsgoml09d7aivlud